General Atlantic, L.P.
Net buyer this quarter
$2.91B
12
+$583M
99.0%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 LFTO | $608M | 20.92% | 14.95% | New | Q2 2026 |
 DLO | $606M | 20.86% | 15.82% | Not reported | Q2 2021 |
 CHYM | $435M | 14.98% | 31.75% | Not reported | Q2 2025 |
 ALKT | $351M | 12.08% | 18.12% | +26.4% | Q2 2021 |
 XP | $334M | 11.50% | Not reported | Not reported | Q4 2019 |
 PHVS | $227M | 7.79% | 10.05% | -18.4% | Q1 2021 |
 SPTX | $133M | 4.56% | 11.40% | New | Q2 2026 |
 NRIX | $73.6M | 2.53% | 2.92% | -26.1% | Q4 2025 |
 RVMD | $67M | 2.31% | 0.17% | -49.5% | Q3 2025 |
 PBLS | $42.1M | 1.45% | 1.26% | New | Q2 2026 |
 RSKD | $26.8M | 0.92% | Not reported | Not reported | Q3 2021 |
 GROV | $3.09M | 0.11% | 5.89% | Not reported | Q2 2022 |
| Q1 2026 | |||||
| DLO | $605M | 28.17% | 15.82% | Not reported | Q2 2021 |
| CHYM | $398M | 18.53% | 31.75% | Not reported | Q2 2025 |
| XP | $392M | 18.23% | Not reported | -9.4% | Q4 2019 |
| ALKT | $240M | 11.19% | 14.45% | +27.9% | Q2 2021 |
| PHVS | $227M | 10.56% | 12.32% | Not reported | Q1 2021 |
| EWCZ | $75.8M | 3.53% | 20.57% | Not reported | Q3 2021 |
| RVMD | $68.8M | 3.20% | 0.35% | -74.8% | Q3 2025 |
| NRIX | $63.6M | 2.96% | 3.97% | -16.2% | Q4 2025 |
| CNTA | $53.8M | 2.50% | 0.88% | -77.9% | Q2 2021 |
| RSKD | $20.9M | 0.97% | Not reported | Not reported | Q3 2021 |
| GROV | $3.17M | 0.15% | 5.89% | Not reported | Q2 2022 |
 BULL | $244K | 0.01% | Not reported | Not reported | Q2 2025 |
| Q4 2025 | |||||
| DLO | $660M | 22.97% | 15.82% | Not reported | Q2 2021 |
| CHYM | $535M | 18.63% | 31.75% | +10.7% | Q2 2025 |
| XP | $372M | 12.93% | Not reported | -11.1% | Q4 2019 |
| ALKT | $277M | 9.63% | 11.30% | Not reported | Q2 2021 |
 ALHC | $260M | 9.05% | 6.45% | -45.8% | Q1 2021 |
| RVMD | $224M | 7.80% | 1.43% | +13.7% | Q3 2025 |
| PHVS | $223M | 7.76% | 12.32% | Not reported | Q1 2021 |
| CNTA | $153M | 5.33% | 4.10% | -36.8% | Q2 2021 |
| NRIX | $92.9M | 3.23% | 4.81% | New | Q4 2025 |
| EWCZ | $47.2M | 1.64% | 20.57% | Not reported | Q3 2021 |
| RSKD | $26.5M | 0.92% | Not reported | Not reported | Q3 2021 |
| GROV | $2.72M | 0.09% | 5.98% | Not reported | Q2 2022 |
| BULL | $395K | 0.01% | Not reported | -99.3% | Q2 2025 |
| Q3 2025 | |||||
| DLO | $666M | 20.00% | 16.34% | -27.0% | Q2 2021 |
| XP | $479M | 14.40% | Not reported | Not reported | Q4 2019 |
| ALHC | $424M | 12.72% | 12.14% | -44.8% | Q1 2021 |
| CHYM | $387M | 11.63% | 28.69% | Not reported | Q2 2025 |
| ALKT | $298M | 8.94% | 11.42% | +24.3% | Q2 2021 |
| AKRO | $272M | 8.17% | 7.15% | Not reported | Q2 2023 |
| CNTA | $235M | 7.05% | 7.20% | Not reported | Q2 2021 |
| PHVS | $200M | 6.02% | 14.77% | +6.6% | Q1 2021 |
| RVMD | $116M | 3.47% | 1.30% | New | Q3 2025 |
| BULL | $106M | 3.20% | Not reported | +0.7% | Q2 2025 |
 RPRX | $52.9M | 1.59% | 0.39% | Not reported | Q2 2020 |
| EWCZ | $52.3M | 1.57% | 20.57% | Not reported | Q3 2021 |
| RSKD | $24.9M | 0.75% | Not reported | Not reported | Q3 2021 |
 ADAG | $7.53M | 0.23% | 6.42% | -1.1% | Q1 2021 |
 ALMS | $5.18M | 0.16% | Not reported | Not reported | Q2 2025 |
| GROV | $3.71M | 0.11% | 6.03% | Not reported | Q2 2022 |